The CDMO's California facility welcomes new production suites, a revamp of its development labs, and more.

The latest news for pharma industry insiders.

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, details the types of regulatory pressures and factors surrounding rising R&D costs that will affect the pharmaceutical industry.

The media company utilized CMS data and worked with Medicare experts to pinpoint qualities that were highly valued to consumers.

The latest news for pharma industry insiders.

The CDMO is investing $3.6 million toward boosting its advanced labeling, automated visual inspection, and fill-finish tech.

Could health system changes that improve patient access to medication have a positive effect on societal welfare?

The latest news for pharma industry insiders.

The collaboration is centered on standardization and the promotion of safety data sharing when it comes to ground handling.

What are their satisfaction rates when it comes to telemedicine visits?

The latest news for pharma industry insiders.

In the first part of this roundtable discussion, a panel of subject matter experts introduce themselves, while discussing why the pharma supply chain sees value in this technology and why its use has fluctuated over the past decade.

The collaboration ultimately benefits oncology patients, as life science companies will be able to access their cancer journey data more efficiently.

The latest news for pharma industry insiders.

Investigators explore this potential association, including how it affects a child’s first two years of life.

The 50,000 square-foot plant is expected to augment the compounding and fulfillment experience for telehealth companies.

The latest news for pharma industry insiders.

A cross-sectional study uses epidemiological patterns to investigate these disparities, while also predicting the potential shift of these patterns by 2050.

The 13,400 square-foot Belgium site will expand the company’s branded standardized bioprocessing, cryopreservation, and distribution solution for the cell therapy market, with a focus on leukapheresis starting materials.

The latest news for pharma industry insiders.

In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jonathan Colehower, managing director, global operations & supply chain practice at UST, explains how the use of blockchain technology will become more prominent moving forward.

The latest news for pharma industry insiders.

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jonathan Colehower, managing director, global operations & supply chain practice at UST, offers his observations as to how stakeholders are building out their networks.

The conference returns to Lyon, France and promises a timely and relevant agenda that attendees will resonate with.